BRUSSELS, July 9 (Reuters) - Trading in shares of Belgian biotech company Innogenetics (INNX.BR: Quote, Profile, Research, Stock Buzz) were suspended before the market opened on Wednesday pending information on the company, the Belgian financial markets regulator CBFA said.
